A Case of ACTH-Secreting Bronchial Carcinoid Abstract #545

Introduction: Ectopic ACTH syndrome (EAS) occurs in about 5-10% of ACTH-dependent hypercortisolism and, in up to 15% of cases, is related to occult neoplasms.
Aim(s): We report one case of EAS highlighting the usefulness of Nuclear Medicine imaging in pre- and intraoperative localization of the ACTH-secreting neoplasm.
Materials and methods: A 66-year-old male patient was diagnosed in 2010 with ACTH-dependent hypercortisolism. Pituitary MRI was negative, while a chest-abdomen CT scan described a 7-mm nodule in the upper lobe of the right lung. Bilateral Inferior Petrosal Sinus Sampling (BIPSS) showed no evidence of center-periphery ACTH gradient. An Octreoscan did not reveal any area of pathological hyperuptake. Treatment with ketoconazole and lanreotide was started with clinical benefit. In July 2011, the patient underwent a PET/CT scan with 68Ga-DOTANOC that revealed mild hyperuptake of the lung nodule.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Prof Laura De Marinis

To read results and conclusion, please login ...

Further abstracts you may be interested in

#303 Pancreatic Metastases from Bronchopulmonary Atypical Carcinoid: An Uncommon Tumor Spreading to a Rare Location
Introduction: We report an uncommon case of pancreatic metastases from a bronchial atypical carcinoid.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Prof Laura De Marinis
#1206 Two Cases of Ectopic ACTH-Secreting Neoplasm of Occult Origin Becoming Overt After Bilateral Adrenalectomy
Introduction: Cushing's syndrome (CS) is an endocrine disorder associated with serious consequences if not adequately treated. Nearly 80% of the cases of endogenous hypercortisolism are adrenocorticotropic hormone (ACTH) dependent, the ACTH source being pituitary in about 70-80% and ectopic in 10-15%. The ACTH source may remain occult in few cases for many years in spite of extensive investigations.
Conference: 12th Annual ENETS Conference (2015)
Category: Clinical cases/reports
Presenting Author: MD Donato Iacovazzo
#301 Medical and Peptide Receptor Radionuclide Therapy (PRRT) with Somatostatin Analogues (SSA) in Well- and Moderately Differentiated Neuroendocrine Tumors
Introduction: PRRT is a treatment choice for inoperable or metastasized neuroendocrine tumors and this therapy seems more effective in the biochemical and volume control of disease than SSA alone.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Prof Laura De Marinis
#1207 A Novel MEN1 Gene Variant in a Sporadic Case of Multiple Endocrine Neoplasia Type 1
Introduction: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by the occurrence of hyperparathyroidism, pituitary adenomas and duodeno-pancreatic neuroendocrine tumours (NETs). Germline mutations of the MEN1 gene are identified in up to 87% of MEN1 families and 82% of isolated MEN1 cases.
Conference: 12th Annual ENETS Conference (2015)
Category: Clinical cases/reports
Presenting Author: MD Donato Iacovazzo
#1522 Non-secreting Pancreatic Neuroendocrine Tumors Co-esistenting with ACTH-dependent Cushing Disease
Introduction: Pancreatic neuroendocrine tumors (pNET) occur occasionally as cause of ectopic ACTH-dependent Cushing disease (ECD).
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: Sabrina Chiloiro
Keywords: NET